Learn more

CHILDRENS HOSPITAL PHILADELPHIA

Overview
  • Total Patents
    411
  • GoodIP Patent Rank
    4,325
  • Filing trend
    ⇩ 3.0%
About

CHILDRENS HOSPITAL PHILADELPHIA has a total of 411 patent applications. It decreased the IP activity by 3.0%. Its first patent ever was published in 2001. It filed its patents most often in United States, Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are THE CHILDREN'S HOSPITAL OF PHILADELPHIA, PANGENE CORPORATION and INST OF OPHTHALMOLOGY.

Patent filings per year

Chart showing CHILDRENS HOSPITAL PHILADELPHIAs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Hakonarson Hakon 97
#2 High Katherine A 50
#3 Kao Charlly 40
#4 Anguela Xavier 29
#5 Davidson Beverly L 27
#6 Flake Alan 21
#7 Davey Marcus 20
#8 Camire Rodney M 19
#9 Glessner Joseph 16
#10 Sleiman Patrick 15

Latest patents

Publication Filing date Title
WO2021077108A1 Method of treating autism
WO2021062233A1 Temperature monitoring and indicator system for a cast saw
WO2021050606A1 Compositions and methods for treatment of disorders associated with clec16a dysfunction or loss
WO2021050608A1 Novel genetic markers for postural orthostatic tachycardia syndrome (pots) and methods of use thereof for diagnosis and treatment of the same
WO2021050445A1 Compositions comprising rare genetic sequence variants associated with pulmonary function and methods of use thereof for diagnosis and treatment of asthma in african american patients
WO2021034903A1 Uroflow monitoring system and method
WO2021030745A1 Combined transgene and intron-derived mirna therapy for treatment of sca1
WO2021021846A1 Antibodies for the diagnosis and treatment of b-cell acute lymphoblastic leukemia
WO2021016062A1 Chimeric antigen receptors containing glypican 2 binding domains
WO2021007410A1 Devices and methods for guidewire management
WO2020264488A1 Compositions and methods for treating anemia
WO2020263777A1 Use of srrd in the inhibition of protein aggregation
WO2020227713A1 Compositions and methods for the treatment of leukodystrophy and whole animal and cellular models for the identifying efficacious agents for treatment of the same
WO2020227406A1 Micro-rna site blocking oligonucleotides for the treatment of epileptic encephalopathy and neurodevelopmental disorders
WO2020223303A1 Compositions and methods for increasing megakaryocyte production
WO2020223315A1 Liquid ventilation for bronchopulmonary dysplasia
WO2020219870A1 Crispr/cas9 gene editing of atxn2 for the treatment of spinocerebellar ataxia type 2
WO2020210275A1 Improved oxygenator for use with extracorporeal support of premature fetus
US2020360491A1 Treatment of lysosomal storage disease in the eye through administration of aavs expressing tpp1
WO2020186148A1 Methods for the detection of brain injury